Herein, CHPA provides feedback on the Agricultural Marketing Service (AMS) request for comments on a Proposed Rule to establish the national mandatory bioengineered food disclosure standard.
These comments are submitted as supporting evidence for the safety of the spray dosage from of sunscreens and is referenced in the comments filed to this docket by PCPC and CHPA.
Scilex Citizen Petition requesting that FDA remove from the market and prevent further marketing of lidocaine-containing drug products that have not been approved pursuant to a new drug application or an abbreviated new drug application submitted under 21 U.S.C. § 355.
Given the millions of units of tooth whitening products used by U.S. consumers and the remarkable safety profile of these products, we believe the U.S. data supports the Colipa recommendation for the marketing of cosmetic tooth whitening products.
On May 7, 2008, CHPA received correspondence from the United States Food and Drug Administration (FDA) requesting safety data for over-the-counter (OTC) mouth rinse products containing cetylpyridinium chloride (CPC).
CHPA has supported and continues to support the timely provision of complete and accurate product information to healthcare professionals and patients in an easily accessible format, and commends the Agency for considering new approaches to disseminating emerging drug safety-related data.
Enclosed herein are comments on "Guidance for Industry; Nonprescription Sunscreen Drug Products - Content and Format of Data Submissions to Support a GRASE determination Under the Sunscreen Innovation Act."
Enclosed are comments regarding the OEHHA draft report entitled " Health Effects Assessment: Potential Neurobehavioral Effects of Synthetic Food Dyes in Children."
